Komori
Kowa (7807) · RiskMitigated

Impact of the COVID-19 pandemic on results and financial position

First written in FY2020. 3 of 10 entries say "Worsened", first in FY2022-Q1. Latest entry: FY2024.

10entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2021-Q1 – FY2022-Q32020: 320202021: 220212022: 120222023: 220232024: 22024
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1252 companies write about · 1264 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1278 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024MitigatedAnnual report

    「Socioeconomic activity moved toward normalization as restrictions on activities and entry from overseas related to COVID-19 were lifted, and COVID-19 was reclassified as a Category V infectious disease in May.」

    The company states that restrictions on activities and entry related to the infectious disease were lifted and that socioeconomic activity moved toward normalization following the Category V reclassification. However, disclosures of risks, including those related to the infectious disease itself, have continued.
  2. FY2024-Q3RestatedAnnual report

    「Restrictions on activities and overseas travel related to COVID-19 were eased, and the economy showed signs of recovery amid a recovery in inbound demand and improvements in employment conditions and the income environment.」

    The company describes the easing of restrictions on activities and overseas travel and the recovery in inbound demand, reconfirming that restrictions on economic activity resulting from the infectious disease are being eased.
  3. FY2024-Q1MitigatedAnnual report

    「A recovery centered on personal consumption was seen as social activity normalized, driven by inbound demand and nationwide travel support following the reclassification of COVID-19 under the Infectious Diseases Control Law and other factors.」

    The company states that personal consumption recovered as the disease classification was changed and social activity began to normalize.
  4. FY2023-Q3RestatedAnnual report

    「The outlook remains uncertain due to risks including the resurgence of COVID-19, the situation in Ukraine and inflation resulting from further yen depreciation.」

    The company states that uncertainty, including the risk of a resurgence of COVID-19, continues.
  5. FY2022-Q3WorsenedAnnual report

    「Although there are signs of an economic recovery, including the government's promotion of vaccinations and the lifting of the state of emergency and priority preventive measures nationwide, the outlook remains uncertain, with new variants also being reported.」

    While describing signs of recovery following the lifting of the state of emergency and other measures, the company states that uncertainty surrounding COVID-19 continues due to the emergence of new variants.
  6. FY2022-Q2WorsenedAnnual report

    「During the cumulative second quarter ended this quarter, Japan's economy remained in difficult conditions. Although some recovery was seen due to the wider availability of vaccines and economic support measures while the end of COVID-19 remained elusive, repeated declarations of a state of emergency and the issuance of priority preventive measures prevented a full recovery. In addition, amid the holding of the Tokyo Olympic and Paralympic Games, the fifth wave of infections spread and breakthrough infections among people who had completed their vaccinations were reported following the emergence of highly transmissible variants, and difficult conditions are expected to continue.」

    In addition to the previous spread of infections and declarations of a state of emergency, the company describes the fifth wave, highly transmissible variants and breakthrough infections, stating that uncertainty surrounding the infectious disease will continue.
  7. FY2022-Q1WorsenedAnnual report

    「During the cumulative first quarter ended this quarter, Japan's economy remained in a difficult and highly uncertain situation, despite some signs of a temporary recovery. Against the backdrop of the spread of COVID-19 variants, the number of infections rose sharply, particularly in the Tokyo metropolitan and Kansai regions, and a third state of emergency was declared.」

    In addition to the previous spread of infections and declarations of a state of emergency, the company describes the spread of variants, the sharp rise in infections and the third state of emergency, indicating that the infection risk is continuing and expanding.
  8. FY2021-Q2MaterialisedAnnual report

    「Even after the state of emergency was lifted, uncertainty about the outlook has persisted due to concerns over a second wave of infections and other factors.」

    The impact of COVID-19 continued, and sales declined 23.2% year on year due to restrictions on movement and the suspension of business activities. Sales also declined in the manufacturing and sales business and the nursing care services business.
  9. FY2021-Q1MaterialisedAnnual report

    「The group's consolidated sales for the cumulative first quarter ended this quarter were ¥1,257 million, down 30.2% year on year, due to the stagnation of economic activity resulting from the government's declaration of a state of emergency and requests for voluntary restraint in response to the spread of COVID-19,」

    The COVID-19 risk, which the company had said at the end of the previous fiscal year could not be reasonably estimated in terms of its impact on results, has materialized as stagnating economic activity and declining sales resulting from the state of emergency and requests for voluntary restraint.
  10. FY2020First statedAnnual report

    「As the spread of COVID-19 led to stay-at-home orders being issued in various parts of the world and a state of emergency being declared in Japan, people have been refraining from going out. These effects may affect the financial position and operating results of the company through the decline in economic activity, including consumption. As of the filing date, it is difficult to reasonably estimate the amount of this impact.」

    Although the spread of the infection and restrictions on going out are described as events that had already occurred, the amount of their impact on the company's results could not be reasonably estimated as of the filing date.
Moved together

"Risk of dilution of share value due to stock acquisition rights" moved the same way as this thread, in the same document, in 5 of its 10 moves.

533222★123456
  1. ★This thread
  2. 1Risk of dilution of share value due to stock acquisition rights5×
  3. 2Sales growth led by walking aids, while OEM sales remained sluggish3×
  4. 3Revenue and Profit Performance3×
  5. 4Research and Development Expenditure2×
  6. 5Dividends paid to shareholders2×
  7. 6Flexible Capital Policy Through Share Repurchases2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Kowa yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of the COVID-19 pandemic on results and financial position | KOWA CO.,LTD. (7807) | Komori